Introduction: Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system (CNS) caused by the reactivation of the John Cunningham vir
Adverse events through 24 weeks in the subset of WOCBP (studies GS-US-320-0110 and GS-US-320-0108; week 96 integrated safety analysis set; reference 21).
*Grade 3/4 adverse events summarised by MedDRA System Organ Class which were reported by 5 or more peoplepy: person yearsClinical outcomes by randomised arm.